Home Cart Sign in  
Chemical Structure| 1508-75-4 Chemical Structure| 1508-75-4

Structure of Tropicamide
CAS No.: 1508-75-4

Chemical Structure| 1508-75-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tropicamide is a mAchR M4 antagonist, used to dilate the pupil and help with examination of the eye.

Synonyms: Ro 1-7683

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tropicamide

CAS No. :1508-75-4
Formula : C17H20N2O2
M.W : 284.35
SMILES Code : O=C(N(CC)CC1=CC=NC=C1)C(C2=CC=CC=C2)CO
Synonyms :
Ro 1-7683
MDL No. :MFCD00058580
InChI Key :BGDKAVGWHJFAGW-UHFFFAOYSA-N
Pubchem ID :5593

Safety of Tropicamide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H315-H317-H319-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • mAChR

    M4 mAChR, IC50:8 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02124486 Idiopathic Intracranial Hypert... More >>ension Less << Not Applicable Active, not recruiting August 2, 2022 United Kingdom ... More >> University Hospital Birmingham (Queen Elizabeth Hospital) Birmingham, West Midlands, United Kingdom, B15 2TH Less <<
NCT00817063 Eczema Phase 3 Completed - -
NCT00227253 - Recruiting December 2025 United States, Texas ... More >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Jannine D Cody, Ph.D.    210-567-9220    cody@uthscsa.edu    Contact: Daniel E Hale, M.D.    210-567-5284    hale@uthscsa.edu    Principal Investigator: Jannine D. Cody, Ph.D.          Sub-Investigator: Peter T. Fox, M.D.          Principal Investigator: Daniel E. Hale, M.D.          Sub-Investigator: Brian P Perry, M.D. Less <<
NCT00817063 - Completed - -
NCT00748059 Autonomic Nervous System Disea... More >>ses Orthostatic Hypotension Dopamine Beta-Hydroxylase Deficiency Orthostatic Intolerance Less << Phase 1 Active, not recruiting December 2018 United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01265719 - Completed - -
NCT01827150 Healthy Early Phase 1 Unknown April 2014 Canada, Quebec ... More >> École d'optométrie de l'Université de Montréal Recruiting Montréal, Quebec, Canada, H3T 1P1 Contact: Liliane Le-Ngoc    5148230615    liliane.linh.lan.le-ngoc@umontreal.ca    Contact: Thuy-Anh Duong    5145707018    thuy-anh.duong@umontreal.ca Less <<
NCT03362580 - Recruiting December 2018 Belgium ... More >> CHU Brugmann Recruiting Brussels, Belgium, 1020 Contact: Laurence Postelmans, MD       laurence.postelmans@chu-brugmann.be Less <<
NCT01265719 - Completed - -
NCT02443129 Retina, Choroid, Sclera Not Applicable Not yet recruiting August 2019 -
NCT01982383 Central Serous Chorioretinopat... More >>hy Less << Not Applicable Terminated(lack of enrollment) - United States, District of Col... More >>umbia George Washington University Medical Faculty Associates Washington, District of Columbia, United States, 20037 Less <<
NCT00459303 - Completed - -
NCT02271373 Myopia Not Applicable Completed - -
NCT02466607 Retinopathy Not Applicable Unknown July 2015 United States, Texas ... More >> Wedgwood Optometry Recruiting Fort Worth, Texas, United States, 76133 Contact: Olga Kraszewska, Ph.D.    682-551-2601    olgakraszewska.phd@gmail.com Less <<
NCT02748031 Congenital Cataract Not Applicable Completed - China, Guangdong ... More >> Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00459303 Cataract Phase 4 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT01075347 - Completed - -
NCT01775007 Measurement of the Elasticity ... More >>of the Anterior Eye Segment Less << Early Phase 1 Unknown January 2014 United States, Massachusetts ... More >> Massachusetts Eye and Ear Infirmary Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Roberto Pineda, MD          Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Natalia Perrotta    617-768-8705    nperrotta@partners.org    Sub-Investigator: Sebastien Besner, PhD          Sub-Investigator: Giuliano Scarcelli, PhD          Principal Investigator: Seok H Yun, PhD          Sub-Investigator: Mehron Puoris'haag, M.D. Less <<
NCT01982383 - Terminated(lack of enrollment) - -
NCT02304861 Cataract Not Applicable Completed - Greece ... More >> University Hospital of Alexandroupolis Alexandroupolis, Evros, Greece, 68100 Less <<
NCT03686436 - Not yet recruiting March 1, 2020 -
NCT01809483 Erosion; Cornea, Traumatic Phase 3 Completed - Indonesia ... More >> Depatment of Ophthalmolohy, Medical Faculty, Udayana University / Sanglah Public General Hospital Denpasar, Bali, Indonesia, 80114 Less <<
NCT02780063 Cataract Not Applicable Not yet recruiting December 2018 United States, New York ... More >> New York University Langone Medical Center Recruiting New York, New York, United States, 10016 Contact: Christopher Lo       loc04@nyumc.org    Principal Investigator: Ann Ostrovsky, MD Less <<
NCT01075347 Corneal Epithelial Defect ... More >> Diabetic Retinopathy Penetrating Keratoplasty Less << Phase 1 Completed - Taiwan ... More >> National Taiwan University Hospital, department of Ophthalmology Taipei, Taiwan, 10047 Less <<
NCT02895074 Cataract Not Applicable Completed - China, Guangdong ... More >> Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT02373137 Keratoplasty ... More >>Grafting, Corneal Transplantation, Corneal Transplantation, Cornea Keratoplasty, Lamellar Less << Phase 4 Active, not recruiting December 2019 United States, California ... More >> Byers Eye Institute, Stanford University Palo Alto, California, United States, 94303 F. I. Proctor Foundation, University of California, San Francisco San Francisco, California, United States, 94143 United States, Oregon Casey Eye Institute, Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT02554396 Presbyopia Phase 2 Completed - United States, Massachusetts ... More >> Andover Eye Associates Andover, Massachusetts, United States, 01810 Less <<
NCT02101359 Cataract Phase 3 Completed - France ... More >> Laboratoires Thea Clermont- Ferrand, France, 63430 Less <<
NCT02023086 - Completed - Canada, Quebec ... More >> Universite de Montreal Montreal, Quebec, Canada, H3T1P1 Less <<
NCT02280135 Retinitis Pigmentosa Phase 1 Completed - Spain ... More >> Clinical Universitary Hospital Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 Less <<
NCT00761137 Sialorrhea Secondary to Parkin... More >>son's Disease Less << Phase 2 Completed - Argentina ... More >> FLENI Hospital Buenos Aires, Argentina Less <<
NCT00761137 - Completed - -
NCT03139708 Intraocular Pressure Phase 1 Completed - United States, North Carolina ... More >> Wake Forest Baptist Health Eye Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00541177 Myopia Phase 4 Unknown March 2008 Taiwan ... More >> Min-Sheng General Hospital Recruiting Tao-Yuan, Taiwan Less <<
NCT00877175 Preterm Infants Phase 4 Completed - Thailand ... More >> Srinagarind Hospital Khon Kaen, Thailand, 40002 Less <<
NCT03448640 - Completed - -
NCT02101359 - Completed - -
NCT00642135 Retinal Anomalies ... More >> Premature Birth Less << Phase 3 Terminated(The total number of... More >> patients has been reached.) Less << June 2008 France ... More >> Hôpital Robert Debré Paris, France, 75019 Less <<
NCT02177539 Refractive Errors Phase 4 Unknown September 2014 Chile ... More >> Pontificia Universidad Catolica de Chile, Departamento de Oftalmología Recruiting Santiago, Chile Contact: Osvaldo H Berger, MD    +56966076844    oberger@uc.cl    Sub-Investigator: Pablo Altschwager, MD          Principal Investigator: Osvaldo H Berger, MD          Principal Investigator: Cristian Salgado, MD          Sub-Investigator: Bernardita Alamos, MD          Sub-Investigator: Silvia Araneda, MD Less <<
NCT00120432 Eye Diseases Phase 3 Completed - Thailand ... More >> Srinagarind Hospital Khon Kaen, Thailand, 40002 Less <<
NCT03097198 Myopia Not Applicable Recruiting December 2018 China, Zhejiang ... More >> School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University Recruiting Wenzhou, Zhejiang, China, 325027 Contact: Lewei Tang, Doctor    +86 15869627364    zhizhezhiwei@163.com Less <<
NCT03751631 Mydriasis Phase 3 Active, not recruiting January 2019 United States, California ... More >> WCCT Cypress, California, United States, 90630 Less <<
NCT03751098 Mydriasis Phase 3 Recruiting January 2019 United States, Texas ... More >> Keystone Research Recruiting Austin, Texas, United States, 78731 Contact: Robert Stapper    512-415-4400    rstapper@keystoneresearchltd.com    R&R Research Active, not recruiting San Antonio, Texas, United States, 78229 Less <<
NCT00690222 Cataract Phac... More >>oemulsification Mydriasis Pseudoexfoliation Syndrome Less << Not Applicable Terminated(Funding) - Canada, Nova Scotia ... More >> Capital District Health Authority Halifax, Nova Scotia, Canada, B3H 2Y9 Less <<
NCT02521116 Healthy Subjects ... More >> Diabetic Retinopathy Retinal Vein Occlusion Less << Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01844648 Sialorrhea (Excessive Drooling... More >>) Less << Phase 2 Completed - France ... More >> Hôpital de la Salpêtrière Paris, Cedrex 13, France, 75651 Hôpital Paul de Viguier Toulouse, Cedrex 9, France, 31059 Hôpital Haut Lévêque Bordeaux, Pessac, France, 33604 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.58mL

3.52mL

1.76mL

35.17mL

7.03mL

3.52mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories